Current Environment:

Kathy Jenkins | Education

Undergraduate School


Colgate University

1982, Hamilton, NY

Medical School

Harvard Medical School

1986, Boston, MA


Boston Children's Hospital

1987, Boston, MA


Boston Children's Hospital

1989, Boston, MA


Boston Children's Hospital

1993, Boston, MA

Kathy Jenkins | Professional History

Dr. Jenkins is a senior member of the Department of Cardiology and is also the Chief Safety and Quality Officer for Boston Children’s Hospital.  She has special expertise in the design and implementation of regulatory trials, and studies variation in outcomes for cardiac surgical procedures, and more recently for other types of pediatric conditions.  She created RACHS-1 (Risk Adjustment for Congenital Heart Surgery), a method to adjust for case mix when evaluating mortality for pediatric heart surgery. She has identified myofibroblastic proliferation as the mechanism for progressive pulmonary vein stenosis, and is running a novel treatment protocol with chemotherapeutic agents.  She teaches clinical research methods, and chairs the department Scientific Review Committee.  She is a national leader in the field of pediatric cardiology, current Chair of the Congenital Heart Public Health Consortium, and a member of leadership councils for the American College of Cardiology and the American Academy of Pediatrics.  She is also the leader of the International Quality Improvement Collaborative for CHD Surgery, aimed at reducing mortality after surgery in the developing world.

Kathy Jenkins | Publications

My interest in medicine grew from a young age when my mother shared stories of the inspiring and challenging work she did as a nurse in pediatrics by the passion and commitment that pediatric providers gave towards vulnerable children and families; in pediatric cardiology with the explosion of innovation and new hope, the complexity of anatomy and physiology, and the emotional burden faced by caregivers and families. I find pulmonary vein stenosis particularly challenging in all these regards though we are making progress. Congenital heart disease is a public health problem for our country and more globally. I lead the quality and safety activities for Boston Children’s Hospital, and for congenital heart disease patients in the United States. I am especially proud of our work helping developing world programs achieve the same success we have seen in the United States. I am an artist and love to use my creativity to bring fresh ideas to our field. The diseases we deal with are very challenging, but every child and family deserves the best we can bring to their unique situation.